Feedback
Settings

Settings

Goto Application

1. WO2005056585 - SARS CORONAVIRUS S PROTEINS AND USES THEREOF

PermaLink
Publication Number WO/2005/056585
Publication Date 23.06.2005
International Application No. PCT/IB2004/004073
International Filing Date 10.12.2004
IPC
C07K 14/165 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
08RNA viruses
165Coronaviridae, e.g. avian infectious bronchitis virus
A61K 39/215 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
215Coronaviridae, e.g. avian infectious bronchitis virus
A61P 31/14 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
14for RNA viruses
C07K 16/10 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
08against material from viruses
10from RNA viruses
C12N 15/50 2006.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09Recombinant DNA-technology
11DNA or RNA fragments; Modified forms thereof
31Genes encoding microbial proteins, e.g. enterotoxins
33Genes encoding viral proteins
40Proteins from RNA viruses, e.g. flaviviruses
50Coronaviridae, e.g. infectious bronchitis virus, transmissible gastroenteritis virus
G01N 33/68 2006.01
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68involving proteins, peptides or amino acids
CPC
A61K 2039/57
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
57characterised by the type of response, e.g. Th1, Th2
A61K 39/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
A61K 39/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
A61K 39/215
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
215Coronaviridae, e.g. avian infectious bronchitis virus
A61P 31/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
A61P 31/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
14for RNA viruses
Applicants
  • AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH [SG]/[SG] (AllExceptUS)
  • CHENG, Kent, H. [US]/[US] (LC)
  • SHEN, Shuo [CN]/[SG] (UsOnly)
  • HONG, Wanjin [SG]/[SG] (UsOnly)
  • LIM, Seng Gee [AU]/[SG] (UsOnly)
  • TAN, Yee Joo [SG]/[SG] (UsOnly)
  • FIELDING, Burtram, Clinton [ZA]/[SG] (UsOnly)
  • GOH, Phuay, Yee [SG]/[SG] (UsOnly)
  • TAN, Timothy Hoe Peng [MY]/[SG] (UsOnly)
  • FU, Jian Lin [SG]/[SG] (UsOnly)
Inventors
  • SHEN, Shuo
  • HONG, Wanjin
  • LIM, Seng Gee
  • TAN, Yee Joo
  • FIELDING, Burtram, Clinton
  • GOH, Phuay, Yee
  • TAN, Timothy Hoe Peng
  • FU, Jian Lin
Agents
  • FALLER, F., Brice
Priority Data
60/528,59610.12.2003US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) SARS CORONAVIRUS S PROTEINS AND USES THEREOF
(FR) PROTÉINES S DU CORONAVIRUS DU SARS ET LEURS UTILISATIONS
Abstract
(EN)
The present invention relates to the use of a matured, glycosylated Spike (S) protein of SARS Coronavirus, fragments of the S protein, methods for producing the same, their use in detecting SARS infection, and their use or the use of their corresponding antibodies to treat patients suffering from SARS.
(FR)
L'invention concerne l'utilisation d'une protéine Spike (S) glycosylée mûrie du coronavirus du SARS (syndrome respiratoire aigu sévère), des fragments de la protéine S, leurs procédés de production, leur utilisation pour détecter l'infection par le SARS et leur utilisation ou l'utilisation de leurs anticorps correspondants pour traiter les patients qui souffrent du SARS.
Also published as
EP1701977
JP2008505050
US20070116716
US2007116716
Latest bibliographic data on file with the International Bureau
# -